{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:56:50Z","timestamp":1792065410772,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.nrleng.2026.502075","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:45:24Z","timestamp":1779839124000},"page":"502075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Appropriate use recommendations of the Spanish Society of Neurology\u2019s Behavioural Neurology and Dementia Study Group on anti-amyloid antibodies in the treatment of Alzheimer disease"],"prefix":"10.1016","volume":"41","author":[{"given":"R.","family":"S\u00e1nchez-Valle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Alcolea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Amer Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Balasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Casado Naranjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Llad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lle\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Martinez Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mart\u00ednez-Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Matias-Guiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mendioroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Perez Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.P.","family":"Ripoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Riverol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sanchez-Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.V.","family":"Bond\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2026.502075_bib0005","unstructured":"Instituto Nacional de Estad\u00edstica. 2024. https:\/\/public.tableau.com\/views\/CAUSAS_DE_MUERTE\/Dashboard1?:showVizHome=no&:embed=true. Acceso 10\/08\/2025."},{"key":"10.1016\/j.nrleng.2026.502075_bib0010","unstructured":"Gu\u00edas diagn\u00f3sticas y terap\u00e9uticas de la Sociedad Espa\u00f1ola de Neurolog\u00eda 2018. Gu\u00eda oficial de pr\u00e1ctica cl\u00ednica en demencias. ISBN: 978-84-17372-34-37."},{"issue":"1","key":"10.1016\/j.nrleng.2026.502075_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1016\/j.nrleng.2026.502075_bib0020","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.nrleng.2026.502075_bib0025","unstructured":"European Medicines Agency. Product information: Leqembi. https:\/\/www.ema.europa.eu\/es\/documents\/product-information\/leqembi-epar-product-information_es.pdfhttps:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/leqembi (documento de aprobaci\u00f3n) Acceso 6\/10\/2025."},{"key":"10.1016\/j.nrleng.2026.502075_bib0030","unstructured":"European Medicines Agency. Product information: Kinsula. https:\/\/ec.europa.eu\/health\/documents\/community-register\/2025\/20250924167377\/anx_167377_es.pdf Acceso 6\/10\/2025."},{"issue":"4","key":"10.1016\/j.nrleng.2026.502075_bib0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1474-4422(25)00024-9","article-title":"Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer\u2019s disease: an open-label extension of the phase 2\/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial","volume":"24","author":"Bateman","year":"2025","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.nrleng.2026.502075_bib0040","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1002\/alz.14315","article-title":"Head-to-head comparison of leading blood tests for Alzheimer\u2019s disease pathology","volume":"20","author":"Schindler","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"25","key":"10.1016\/j.nrleng.2026.502075_bib0045","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: positioning document and usage recommendations from the Behavioral Neurology and Dementia Study Group of the Spanish Society of Neurology","volume":"S2173-5808","author":"Su\u00e1rez-Calvet","year":"2025","journal-title":"Neurologia (Engl Ed)"},{"issue":"3","key":"10.1016\/j.nrleng.2026.502075_bib0050","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use recommendations","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prev Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.nrleng.2026.502075_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100150","article-title":"Donanemab: appropriate use recommendations","volume":"12","author":"Rabinovici","year":"2025","journal-title":"J Prev Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.nrleng.2026.502075_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100094","article-title":"Lecanemab for early Alzheimer\u2019s disease: appropriate use recommendations from the French federation of memory clinics","volume":"12","author":"Villain","year":"2025","journal-title":"J Prev Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.nrleng.2026.502075_bib0065","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","article-title":"APOE4 homozygozity represents a distinct genetic form of Alzheimer\u2019s disease","volume":"30","author":"Fortea","year":"2024","journal-title":"Nat Med."},{"issue":"6","key":"10.1016\/j.nrleng.2026.502075_bib0070","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/GIM.0b013e31821d69b8","article-title":"Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the american college of medical genetics and the national society of genetic counselors","volume":"13","author":"Goldman","year":"2011","journal-title":"Genetics Med."},{"issue":"1","key":"10.1016\/j.nrleng.2026.502075_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000334607","article-title":"Prevalence of Apolipoprotein E4 Genotype and Homozygotes (APOE E4\/4) among patients diagnosed with Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"38","author":"Ward","year":"2012","journal-title":"Neuroepidemiology."},{"issue":"5","key":"10.1016\/j.nrleng.2026.502075_bib0080","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamaneurol.2025.0065","article-title":"Amyloid-related imaging abnormalities with donanemab in early symptomatic Alzheimer disease: secondary analysis of the TRAILBLAZER-ALZ and ALZ 2 randomized clinical trials","volume":"82","author":"Zimmer","year":"2025","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/j.nrleng.2026.502075_bib0085","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/jamaneurol.2025.1232","article-title":"Lecanemab treatment in a specialty memory clinic","volume":"82","author":"Paczynski","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nrleng.2026.502075_bib0090","series-title":"\u00bfEst\u00e1 nuestro Sistema Sanitario preparado para las terapias anti-amiloide u otras terapias modificadoras de la enfermedad? Comunicaci\u00f3n oral","author":"Escudero","year":"2023"},{"issue":"4","key":"10.1016\/j.nrleng.2026.502075_bib0095","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70062","article-title":"Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction","volume":"21","author":"Wang","year":"2025","journal-title":"Alzheimers Dement"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217358082600101X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217358082600101X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:35:06Z","timestamp":1792064106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S217358082600101X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S217358082600101X"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2026.502075","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appropriate use recommendations of the Spanish Society of Neurology\u2019s Behavioural Neurology and Dementia Study Group on anti-amyloid antibodies in the treatment of Alzheimer disease","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2026.502075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2026.502075","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Neurolog\u00eda.","name":"copyright","label":"Copyright"}],"article-number":"502075"}}